Abiraterone acetate

154229-18-2

17-(3-Pyridyl)-5,16-androstadien-3beta-acetate; trade name: Zytiga^®

A CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.

02/02/2016

Reproductive Toxicity:	Currently listed

Listed for:	Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Developmental Toxicity
Date of Listing:	04/08/2016
Basis for Listing:	Formally Required
Male Reproductive Toxicity
Date of Listing:	04/08/2016
Basis for Listing:	Formally Required
Female Reproductive Toxicity
Date of Listing:	04/08/2016
Basis for Listing:	Formally Required

Reproductive Toxicity:	Abiraterone Acetate Listed Effective April 8, 2016 as Known to the State of California to Cause Reproductive Toxicity Apr 8, 2016